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BACKGROUND AND PURPOSE: The prevalence of unruptured intracranial aneurysms (UIAs) in the adult population is ≈3%. 
Rupture of an intracranial aneurysm can have devastating consequences, which emphasizes the importance of identification 
of potentially modifiable determinants for the presence and size of UIAs. Our aim was to study the association of a broad 
spectrum of potential determinants with the presence and size of UIAs in a general adult population.
METHODS: Between 2005 and 2015, 5841 participants from the population-based Rotterdam Study (mean age, 64.4 
years, 45.0% male) underwent brain magnetic resonance imaging (1.5T). These scans were evaluated for the presence of 
incidental UIAs. We determined number and volume of the UIAs. Using logistic and linear regression models, we assessed 
the association of cardiovascular, lifestyle and emerging inflammatory and hormonal determinants with the presence and 
volume of UIAs.
RESULTS: In 134 (2.3%) participants, ≥1 UIAs were detected (149 UIAs in total), with a median volume of 61.1 mm3 
(interquartile range, 33.2–134.0). In multivariable models, female sex (odds ratio, 1.92 [95% CI, 1.33–2.84]), hypertension 
(odds ratio, 1.73 [95% CI, 1.13–2.68]), and current smoking (odds ratio, 3.75 [95% CI, 2.27–6.33]) were associated with 
the presence of UIAs. We found no association of alcohol use, physical activity, or diet quality with UIA presence. Finally, we 
found white blood cell count to relate to larger aneurysm volume (difference in volume of 33.6 mm3 per 109/L increase in 
white blood cell [95% CI, 3.92–63.5]).
CONCLUSIONS: In this population-based study, female sex, hypertension, and smoking, but no other lifestyle determinants, were 
associated with the presence of UIAs. White blood cell count is associated with size of UIAs. Preventive strategies should 
focus on treating hypertension and promoting cessation of smoking.
Key Words: female ◼ inflammation ◼ intracranial aneurysm ◼ lifestyle ◼ subarachnoid hemorrhage
Unruptured intracranial aneurysms (UIAs) occur in ≈3% of the adult population,1–3 of whom ≈20% to 30% harbor multiple UIAs.4 Given the potentially 
devastating consequences of rupture of such aneu-
rysms, development of preventive strategies for intra-
cranial aneurysm formation is key. Yet, to develop such 
preventive strategies, detailed knowledge on cause 
is required. Over the last decades, several studies on 
risk factors for UIAs have been performed. However, 
these studies were generally performed in small, highly 
selected populations, including populations of patients 
with previous aneurysmal subarachnoid hemorrhage5–7 
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or patients with a genetically increased risk (eg, the Finn-
ish population).5,8,9
Unfortunately, data on the cause of UIAs in unselected, 
community-dwelling individuals remain scarce. Therefore, 
it is important to assess the role of previously established 
major risk factors (eg, female sex, hypertension, and 
smoking6–8) in the general population, while also shed-
ding light on additional potentially modifiable risk factors, 
including lifestyle and inflammation. Evidence shows that 
adhering to a healthy lifestyle, including, for example, a 
healthy diet and regular physical activity, decreases the 
risk of other cardiovascular diseases (CVDs), including 
stroke.10,11 Nonetheless, little is known about an asso-
ciation between lifestyle, which consists of largely modi-
fiable risk factors, and the presence of UIAs. Improved 
knowledge about the determinants is paramount and 
may provide important handholds for future prevention of 
intracranial aneurysms.
Besides preventing aneurysm formation, another way 
of preventing aneurysm rupture is by limiting its growth. 
Growth and size, which can be seen as a surrogate 
marker for aneurysms grown in the past, both have been 
shown to be associated with risk of aneurysm rupture.12 
As the causes of aneurysmal growth are incompletely 
understood, it is important to first investigate novel 
potential determinants for increased aneurysm size.
Given the above, the aim of this study was to inves-
tigate the association of a broad range of determinants 
with presence and size of UIAs in the general adult pop-
ulation, with a focus on the role of lifestyle.
METHODS
Settings and Study Population
This cross-sectional study was embedded in the Rotterdam 
Study, a population-based, prospective study cohort in over 
14 000 adults aged 45 or over, located in Ommoord, a neigh-
borhood in Rotterdam, the Netherlands.13 Ninety-six percent of 
the participants is of white descent. Participants were invited to 
undergo a range of extensive examinations at study entry and 
subsequently every 3 to 4 years at a dedicated study center. 
These examinations ranged from elaborate questionnaires to 
medical imaging, such as magnetic resonance imaging (MRI).
Since 2005, brain MRI examination has been incorporated 
in the study protocol and provided to all participants without 
contraindications as part of the Rotterdam Scan Study, which 
was embedded in the original Rotterdam Study. Between 2005 
and 2015, 5841 unique persons have undergone MRI of the 
brain, which comprises the population for the current study. 
Assessment of UIAs was not incorporated in the original study 
aim but was part of a review of all scans for potentially relevant 
incidental findings.3
Requests to access the data set from qualified researchers 
trained in human subject confidentiality protocols may be sent 
to the Department of Epidemiology, Erasmus MC University 
Medical Center at f.vanrooij@erasmusmc.nl. The Rotterdam 
Study has been approved by the Medical Ethics Committee 
of the Erasmus MC (registration number MEC 02.1015) and 
by the Dutch Ministry of Health, Welfare and Sport (Population 
Screening Act WBO, license number 1071272-159521-PG). 
The Rotterdam Study has been entered into the Netherlands 
National Trial Register (www.trialregister.nl) and into the World 
Health Organization International Clinical Trials Registry 
Platform (www.who.int/ictrp/network/primary/en/) under 
shared catalogue number NTR6831.13 All participants provided 
written informed consent to participate in the study and to have 
their information obtained from treating physicians.
Assessment of UIAs
A study-dedicated 1.5T MRI unit with an 8-channel head coil 
(General Electric Healthcare, Milwaukee) was used for brain 
MRI.14 The MRI protocol, as described elsewhere,13 con-
sisted of 4 high-resolution axial sequences: a 3-dimensional 
T1-weighted sequence; a 2-dimensional proton-density-
weighted (PDw) sequence; a 2-dimensional fluid-attenuated 
inversion recovery sequence; and a 3-dimensional T2-weighted 
gradient-recalled echo sequence. There was no administration 
of contrast material.
Per protocol, every brain MRI scan was rated within 2 
weeks of acquisition for the presence of incidental findings 
by trained research physicians3 and assessed for intracranial 
aneurysms on the PDw sequence (see example in the Figure). 
All potential intracranial aneurysms reported by research phy-
sicians were reassessed by experienced neuroradiologists and 
were categorized properly for location and size. According to 
our management of incidental findings protocol,3 all persons 
with an aneurysm in the posterior circulation or an aneurysm 
>7 mm in the anterior circulation were directly referred for 
further clinical evaluation. After subsequent clinical diagnostic 
imaging (ie, computed tomography angiography or magnetic 
resonance angiography), these participants were all proven to 
actually harbor a UIA, indicating a low false-positive rate. None 
of the participants had a history of subarachnoid hemorrhage 
at baseline.
All intracranial aneurysms, regardless of referral, were man-
ually segmented by a single rater on axial PDw slices using 
MeVisLab 2.6.1 (MeVis Medical Solutions AG). Manual seg-
mentation was used for a 3-dimensional reconstruction, yield-
ing maximum diameter and volume for each aneurysm. For 4 
participants, it was not possible to estimate maximum diameter 
or volume because of motion artifacts on the PDw scan. A ran-
dom subset (n=20) of scans was segmented separately by an 
independent rater to assess the interrater intraclass correlation 
coefficient of maximum diameter (intraclass correlation coeffi-
cient=0.71) and volume (intraclass correlation coefficient=0.87).
Assessment of Determinants
We divided the potential determinants into 3 categories: cardio-
vascular, lifestyle, and emerging determinants. Cardiovascular 
determinants were body mass index hypertension, smoking, 
hypercholesterolemia, diabetes mellitus, and history of CVD. 
Height (cm) and weight (kg) were measured under stan-
dardized conditions, and body mass index was calculated as 
weight/height2 (kg/m2). Blood pressure was measured twice 
using a random zero sphygmomanometer, and the average was 
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taken. Hypertension was defined as a systolic blood pressure 
≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, and/
or use of blood pressure–lowering medication. Smoking sta-
tus was acquired through home interviews and was catego-
rized into never, former, and current smoking. Cholesterol and 
glucose levels were measured using fasting blood samples.15 
Hypercholesterolemia was defined as total cholesterol concen-
tration ≥6.2 mmol/L and/or use of lipid-lowering medication. 
Diabetes mellitus was defined as having fasting blood glucose 
concentrations >7.0 mmol/L and/or nonfasting blood glucose 
>11.1 mmol/L and/or use of glucose-lowering medication. 
CVD history was defined as having a history of stroke, myocar-
dial infarction, or percutaneous coronary intervention.
Our assessment of lifestyle consisted of a diet adherence 
score, a physical activity score, and use of alcohol. Dietary 
intake was assessed with a validated self-administered food 
frequency questionnaire consisting of 389 items, based on 
which we evaluated the adherence (yes/no) of the participants 
to 14 items of the Dutch dietary guidelines. By adding the 
adhered items, a score between 0 and 14 was obtained, with 
a higher score reflecting better diet quality.16 Physical activ-
ity was assessed using the validated17,18 Longitudinal Ageing 
Study Amsterdam (LASA) physical activity questionnaire, which 
contains questions about frequency and duration of a range 
of physical activities (walking, cycling, gardening, sports, and 
housekeeping16). For each participant, these data were con-
verted into metabolic equivalent of task-hours per week.19 
Finally, alcohol consumption was measured through home 
interviews and was converted to a universal unit (g/day, where 
10 g of alcohol equals 1 glass).
Assessment of emerging determinants consisted of inflam-
matory markers (CRP [C-reactive protein] and white blood cell 
[WBC] count) and a hormonal marker (estradiol). These bio-
markers were all obtained through a fasting blood sample.15
Statistical Analysis
To assess the association of the determinants with the pres-
ence of UIAs, we used logistic regression models. In the first 
set of models (model 1), we investigated the determinants 
individually, while adjusting for sex and age. In the second set 
of models (model 2), we additionally adjusted for all cardio-
vascular determinants (body mass index, hypertension, smok-
ing, hypercholesterolemia, diabetes mellitus, CVD history). As 
data on diet score, physical activity, alcohol intake, CRP, WBC 
count, and estradiol were only collected in specific subcohorts, 
we decided not to include these determinants in model 2 (see 
below). Associations of estradiol levels with UIAs were ana-
lyzed stratified by sex, given the fundamentally different distri-
bution of estradiol levels between males and females.
To assess whether the potential determinants were associ-
ated with aneurysm volume, we used linear regression while 
adjusting for confounders using models 1 and 2. This analysis 
was limited to the 130 participants with aneurysms, in whom 
aneurysm volume could be calculated. We reported both mod-
els, as model 1 mainly serves a descriptive purpose, whereas 
model 2 primarily determines the independent relationship of 
the determinants with UIA presence and volume.
In the total cohort, we had missing values for body mass 
index (0.4%), hypertension (0.5%), systolic blood pressure 
and diastolic blood pressure (0.4%), blood pressure–lowering 
medication (0.6%), smoking status (0.6%), total cholesterol 
and non-HDL (high-density lipoprotein) cholesterol (1.7%), 
lipid-lowering medication (0.6%), fasting glucose (1.7%), dia-
betes mellitus (1.2%), alcohol intake (5.7%), and WBC count 
(0.01%). In the subgroup used for analysis of aneurysm volume, 
these values ranged from 0% to 3.7%. Missing values for these 
variables were imputed using the expectation-maximization 
algorithm based on the cardiovascular variables, WBC count, 
alcohol intake, and aneurysm presence. Some measurements 
were only performed in specific subcohorts of the Rotterdam 
Study, resulting in limited available data on such variables. 
Accordingly, diet score, physical activity, CRP, and estradiol 
were available in only 77.7%, 62.1%, 49.8%, and 49.6% of 
the participants, respectively. For these variables, we analyzed 
the data using complete-case analysis, while still adjusting for 
other variables in models 1 and 2. For data analysis, R version 
3.4.1 was used (www.cran.r-project.org).
Figure. Unruptured intracranial 
aneurysm on brain MRI.  
Arrow indicates an aneurysm of the 
anterior communicating artery (diameter, 
10 mm) on the proton-density-weighted 
image.
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RESULTS
In nearly all cases, the MRI scan was acquired after the 
assessment of determinants, with a median time interval 
of 20 days (interquartile range, 12–56). The mean age at 
time of brain MRI was 64.4 years (SD=10.9 years), and 
55.0% of participants were female (Table 1). The preva-
lence of UIAs was 2.3% (95% CI, 1.9–2.7), with a preva-
lence of 2.9% (95% CI, 2.3–3.4) in females and 1.7% 
(95% CI, 1.2–2.1) in males, respectively. Median maxi-
mum diameter of UIAs was 5.7 mm (interquartile range, 
4.6–8.2) and median volume 61.1 mm3 (interquartile 
range, 33.2–134.0). Almost all aneurysms were saccular 
(95.3%). Most frequently affected artery was the anterior 
communicating artery (16.8%). Only 6 aneurysms (4.1%) 
were located in the posterior circulation.
In age- and sex-adjusted analyses, we found female 
sex (odds ratio [OR], 1.75 [95% CI, 1.22–2.54]), hyper-
tension (OR, 1.52 [95% CI, 1.02–2.30]), smoking (OR, 
3.89 [95% CI, 2.38–6.50]), CVD history (OR, 1.91 [95% 
CI, 1.12–3.11]), and WBC count (OR, 1.11 per 109/L 
increase [95% CI, 1.04–1.19]) to be associated with the 
presence of UIAs (Table 2, model 1). In the fully adjusted 
analyses, female sex (OR, 1.92 [95% CI, 1.33–2.84]), 
hypertension (OR, 1.73 [95% CI, 1.13–2.68]), and smok-
ing (OR, 3.75 [95% CI, 2.27–6.33]) remained associated 
with presence of UIAs (Table 2, model 2).
In age- and sex-adjusted analyses, we did not find 
any of the determinants to be associated with volume 
(Table 3) of UIAs. In fully adjusted analyses, only WBC 
count was found to relate to aneurysm volume (β=33.6 
mm3 per 109/L increase [95% CI, 3.92–63.5]). After 
stratifying for sex (Tables I and II in the Data Supple-
ment), we found that only in females, WBC count was 
associated with aneurysm volume (β=39.3 mm3 per 
109/L increase [95% CI, 0.35–78.2)).
DISCUSSION
In this study among middle-aged and elderly community-
dwelling individuals, we found female sex, hypertension, 
and smoking to be associated with the presence of an 
UIA. Other lifestyle factors, such as alcohol use, diet, and 
physical activity, did not influence the presence of UIAs. 
We found WBC count to be associated with volume of 
UIAs in the general population.
The results of this study are largely in agreement 
with results from previous research. However, the effect 
of female sex appears to be less strong in the general 
population than a previous clinical study among patients 
with a history of subarachnoid hemorrhage indicated.8 
Besides obvious differences in study population, which 
may explain this, another interesting explanation of this 
difference may also be that women are more prone to 
aneurysm rupture than men. Nevertheless, that would be 
in contrast with the largest meta-analysis investigating 
risk factors for aneurysm rupture,9 which did not find 
female sex as a risk factor for aneurysm rupture. Fur-
thermore, our reported prevalence of posterior circulation 
aneurysms is lower than in previous studies.2 This can 
be explained by their tendency to be smaller, leading to 
lower detection and thus an underestimation in our study, 
as we did not use diagnostic computed tomography or 
magnetic resonance angiography. An alternative expla-
nation for the discrepancy is the higher prevalence of 
such aneurysms in populations with comorbidities, which 
were overrepresented in previous studies, than in the 
general population. Finally, these aneurysms are more 
prone to rupture,9 which may have led to underrepresen-
tation in the current study.
Hypertension is thought to exert its effect on formation 
of UIAs by increasing hemodynamic stress on cerebral 
vessel walls and subsequent remodeling of the vessel 
wall.20 As previous research suggests that hypertension 
is associated with increased risk of aneurysm growth,6 
and thus potentially with aneurysm size, it is possible that 
hypertension causes aneurysm growth through similar 
mechanisms. Nonetheless, we did not find a relationship 
between aneurysm size and hypertension in the general 
population. This may be partly explained by the fact that 
a considerable number of participants with hypertension 
use antihypertensive medication, thereby attenuating the 
association. Conversely, it is possible that daily or long-
term fluctuations in blood pressure influence aneurysm 
presence and size. Investigating such an association 
requires long-term and extensive blood pressure moni-
toring but may be helpful in dissecting the cause of UIAs.
Several studies5–8 have previously demonstrated the 
considerable, detrimental effects of smoking on aneu-
rysm formation, although the exact pathophysiological 
pathways remain undefined. The findings of this study 
support these studies and point to smoking as one of 
the major known modifiable risk factors of aneurysm 
presence. Preventative measures of UIAs focusing on 
cessation of smoking may therefore prove to be highly 
successful. There was an incremental increase in risk of 
aneurysm presence across nonsmokers, previous smok-
ers, and current smokers, which supports the hypothesis 
that cessation of smoking may at any given moment 
prove helpful in prevention of intracranial aneurysms.
Despite playing a considerable part in many CVDs, 
such as coronary heart disease and stroke,10,11 we found 
no role of other lifestyle factors, such as alcohol use, diet, 
and physical activity, in aneurysm presence. These find-
ings may call into question the efficacy of potential inter-
ventions focused on improving diet and physical activity 
and limiting alcohol use to prevent formation of intracra-
nial aneurysms. However, it is possible that such interven-
tions decrease the risk of aneurysm formation through 
other pathways, such as lowering blood pressure.
Interestingly, our study found WBC count to be asso-
ciated with presence of UIAs. However, after adjusting 
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for cardiovascular risk factors, this effect did not remain 
statistically significant. Moreover, WBC count was asso-
ciated with increased aneurysm volume. Nonetheless, as 
this association would not survive a multiple comparison 
correction, it should be approached with caution. There 
is a growing body of evidence implicating inflamma-
tion in the formation of UIAs. Prior research has shown 
an association between WBC count and incidence of 
subarachnoid hemorrhage.21 Our study suggests that 
this association may be driven by an increased risk of 
Table 1. Characteristics of the Study Population
Characteristic
 Participants With
All Participants Aneurysm No Aneurysm
No. of participants (% of total) 5841 (100.0) 134 (2.3) 5707 (97.7)
Age, y 64.4±10.9 65.0±11.7 64.4±10.8
Female sex 3214 (55.0) 91 (67.9) 3123 (54.7)
BMI, kg/m2 27.5±4.19 27.0±3.89 27.5±4.19
 Obese (BMI≥30 kg/m2) 1352 (23.3) 26 (19.4) 1326 (23.3)
Hypertension 3721 (64.0) 96 (71.6) 3625 (63.8)
SBP, mm Hg 140.1±21.6 140.7±23.5 140.1±21.6
DBP, mm Hg 82.6±11.0 82.5±12.4 82.6±11.0
Use of blood pressure–lowering medication 2099 (36.2) 62 (46.2) 2037 (35.9)
Smoking status
 Never smoker 1874 (32.2) 26 (19.4) 1848 (32.5)
 Previous smoker 2942 (50.6) 63 (47) 2879 (50.7)
 Current smoker 991 (17.1) 45 (33.6) 946 (16.7)
Hypercholesterolemia 2410 (41.3) 64 (47.8) 2346 (41.1)
Total cholesterol, mmol/L 5.53±1.06 5.57±1.07 5.53±1.06
Non-HDL cholesterol, mmol/L 4.08±1.03 4.19±1.07 4.08±1.03
Use of lipid-lowering medication 1471 (25.3) 40 (29.9) 1431 (25.2)
Fasting glucose, mmol/L 5.64±1.24 5.51±0.77 5.64±1.24
Diabetes mellitus 749 (13.0) 12 (9.1) 737 (13.1)
Cardiovascular history 572 (9.8) 20 (15.0) 552 (9.7)
 History of stroke 171 (2.9) 7 (5.3) 164 (2.9)
 History of CHD 372 (6.4) 10 (7.5) 362 (6.4)
 History of both 29 (0.5) 3 (23) 26 (0.5)
Diet quality score* 6.87±1.89 6.79±2.04 6.87±1.88
Physical activity, MET-hours/wk† 29.5 (13.0–65.2) 25.8 (25.8–59.4) 29.6 (13.1–65.2)
Alcohol intake, g/d 9.34±10.45 8.43±9.29 9.36±10.47
CRP, mg/L 2.89±17.13 2.58±2.73 2.90±17.32
WBC count, 109/L 6.91±1.91 7.4±1.99 6.90±1.90
Estradiol, pmol/L 113.41±217.8 121.1±210.1 113.2±218.1
No. of aneurysms … 149 …
 Saccular aneurysms … 142 (95.3) …
 Fusiform aneurysms … 7 (4.7) …
 Maximum diameter, mm† … 5.7 (4.6–8.2) …
 Volume, mm3† … 61.1 (33.2–134.0) …
Missing values were present for body mass index (0.4%), hypertension (0.5%), SBP and DBP (0.4%), blood pressure–lowering 
medication (0.6%), smoking status (0.6%), total cholesterol and non-HDL cholesterol (1.7%), lipid-lowering medication (0.6%), 
fasting glucose (1.7%), diabetes mellitus (1.2%), diet score (22.3%), physical activity (37.9%), alcohol intake (5.7%), CRP (50.2%), 
WBC count (0.01%), and estradiol (50.4%). Hypertension is defined as SBP ≥140 mm Hg, DBP ≥90 mm Hg and/or use of blood 
pressure–lowering medication. Hypercholesterolemia is defined as serum total cholesterol ≥6.2 mmol/L and/or use of lipid-lowering 
medication. BMI indicates body mass index; CHD, coronary heart disease, meaning history of myocardial infarction or percutaneous 
coronary intervention; CRP, C-reactive protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; MET, metabolic 
equivalent of task; SBP, systolic blood pressure; and WBC, white blood cell.
*Diet score ranges from 0 to 10, with higher scores representing better diet quality.
†Values are mean±SD for continuous variables or median (interquartile range) and absolute numbers (percentage) for categorical 
variables.
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aneurysm presence. Moreover, previous imaging stud-
ies22–24 have demonstrated vessel wall changes related 
to inflammation in aneurysms. Circumferential enhance-
ment along the aneurysm wall on MRI, likely a reflection 
of inflammation activity, was associated with aneurysm 
growth (and thus size), further supporting this pathway 
and highlighting a potential diagnostic or prognostic 
role for imaging studies in aneurysm development and 
growth.23,24 Finally, data from a case-control study sug-
gest that anti-inflammatory therapies (eg, aspirin) may 
potentially limit aneurysm rupture,25 possibly in part 
through inhibition of aneurysm growth. A randomized 
controlled trial investigating the effects of aspirin and 
intensive blood pressure lowering on aneurysm rupture 
and growth is currently ongoing.26 The role of inflamma-
tion in aneurysm development remains controversial, and 
our findings should be regarded as hypothesis-generat-
ing rather than conclusive evidence.
Despite previous efforts, the pathophysiologi-
cal mechanisms behind sex differences in aneurysm 
presence remain obscure. Hormones are a fundamental 
part of sex differences and may be the main underly-
ing cause of sex differences in aneurysm prevalence. To 
shed light on this topic, we investigated the association 
of estradiol levels with UIAs. Nevertheless, we did not 
find an association between estradiol levels and aneu-
rysm presence or volume. However, it must be pointed 
out that the majority of women in our study was (post-)
menopausal and that we did not have data on their pre-
menopausal estradiol levels. As prevalence of intracra-
nial aneurysms quickly increases among women after 
menopause,1 it is possible that not so much the post-
menopausal level of estrogens, but more the shift in 
estrogen levels, is a risk factor for aneurysm formation. 
Table 2. Determinants for the Presence of Unruptured 
Intracranial Aneurysms
Odds Ratio of Presence of Aneurysm
Model 1 Model 2
Cardiovascular
 Female sex 1.75 (1.22–2.54) 1.96 (1.35–2.88)
 Age (per 10 y) 1.05 (0.90–1.23) 1.04 (0.87–1.24)
 BMI (per kg/m2) 0.97 (0.93–1.01) 0.97 (0.93–1.02)
 Hypertension 1.52 (1.02–2.30) 1.66 (1.09–2.57)
 Smoking
  Never smoking Ref. Ref.
  Previous smoking 1.72 (1.09–2.79) 1.69 (1.07–2.74)
  Current smoking 3.89 (2.38–6.50) 3.78 (2.30–6.33)
 Hypercholesterolemia 1.28 (0.91–1.81) 1.13 (0.79–1.61)
 Diabetes mellitus 0.66 (0.34–1.16) 0.61 (0.31–1.10)
 CVD history 1.83 (1.08–2.98) 1.55 (0.90–2.56)
Lifestyle
 Diet quality score (per point 
increase)
0.96 (0.86–1.07) 1.00 (0.90–1.11)
 Physical activity (per 10 MET-
hours/wk)
1.01 (0.96–1.04) 1.01 (0.96–1.04)
 Alcohol (per glass/d) 1.00 (0.98–1.02) 0.99 (0.97–1.01)
Emerging
 CRP (per mg/L) 1.00 (0.93–1.01) 1.00 (0.93–1.04)
 WBC count (per 1×109/L) 1.12 (1.04–1.19) 1.07 (0.98–1.15)
 Estradiol (per 100 pmol/L)
  Male 0.64 (0.15–2.23) 0.74 (0.16–2.95)
  Female 0.99 (0.87–1.08) 1.00 (0.88–1.09)
Values represent odds ratios for having a unruptured intracranial aneurysm 
(UIA) with 95% CI. Model 1: Adjusted for sex and age. Model 2: Adjusted for 
sex, age, BMI, hypertension, smoking status, hypercholesterolemia, CVD history, 
and diabetes mellitus. BMI indicates body mass index; CRP, C-reactive protein; 
CVD, history of stroke or coronary heart disease, meaning history of myocardial 
infarction or percutaneous coronary intervention; MET, metabolic equivalent of 
task; and WBC, white blood cell.
Table 3. Determinants of Volume of Unruptured Intracranial 
Aneurysms
Difference in Aneurysm Volume (mm3 per Unit 
Increase*)
Model 1 Model 2
Cardiovascular
 Female sex 22.6 (−94.6 to 139.9) 2.0 (−120.7 to 124.6)
 Age (per 10 y) 26.6 (−20.0 to 73.2) 21.1 (−32.1 to 74.3)
 BMI (per kg/m2) −9.7 (−23.8 to 4.3) −12.2 (−27.2 to 2.8)
 Hypertension 2.5 (−129.3 to 134.3) 7.8 (−130.3 to 145.9)
 Smoking
  Never smoking Ref. Ref.
  Previous smoking −75.5 (−220.8 to 69.8) −90.7 (−238.5 to 57.2)
  Current smoking −92.0 (−252.4 to 68.4) −119.5 (−282.8 to 43.9)
 Hypercholesterolemia 76.8 (−30.7 to 184.4) 79.6 (−32.3 to 191.6)
 Diabetes mellitus 4.4 (−191.1 to 200.0) 49.1 (−160.1 to 258.4)
 CVD history 9.8 (−147.7 to 167.3) −8.6 (−175.4 to 158.3)
Lifestyle
 Diet quality score (per 
point increase)
−13.6 (−34.8 to 7.54) −14.6 (−36.6 to 7.4)
 Physical activity (per 
10 MET-hours/wk)
−5.5 (−18.8 to 7.9) −6.6 (−20.3 to 7.1)
 Alcohol (per glass/d) 2.0 (−4.5 to 8.4) 2.4 (−4.2 to 9.1)
Emerging
 CRP (per mg/L) −9.6 (−34.1 to 14.9) −3.0 (−33.0 to 27.0)
 WBC count (per 
1×109/L)
24.1 (−3.1 to 51.3) 32.6 (3.7 to 61.5)
 Estradiol (per 100 pmol/L)
  Male −123.2 (−792.5 to 546.0) 229.1 (−1169 to 1628)
  Female 0.33 (−24.6 to 25.2) 0.58 (−28.2 to 27.1)
Missing values were present for hypercholesterolemia (1.5%), diabetes mellitus 
(1.5%), diet score (22.4%), physical activity (45.5%), alcohol intake (3.7%), CRP 
(50.7%), WBC count (1.5%), and estradiol (50.7%). Values represent difference 
in aneurysm volume with 95% CI. One hundred thirty participants included in 
analysis. Model 1: Adjusted for sex and age. Model 2: Adjusted for sex, age, BMI, 
hypertension, smoking status, hypercholesterolemia, CVD history, and diabetes 
mellitus. BMI indicates body mass index; CRP, C-reactive protein; CVD, history 
of stroke or coronary heart disease, meaning history of myocardial infarction or 
percutaneous coronary intervention; MET, metabolic equivalent of task; and WBC, 
white blood cell.
*Unless indicated differently.
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Longitudinal data, especially from younger subjects, are 
necessary to further investigate this.
Sex, hypertension, and smoking have previously been 
shown to be risk factors for aneurysm growth.6,8 We 
therefore hypothesized that these determinants would 
also relate to aneurysm size in the general population. 
Nonetheless, besides WBC count, we did not find any 
of the determinants to be associated with aneurysm vol-
ume. A potential explanation is that certain determinants 
(eg, smoking and hypertension) cause rupture early after 
growth, thereby causing underrepresentation of these 
determinants among those with large aneurysms.27 How-
ever, as the vast majority of aneurysms were similar in 
volume, it is possible that we did not find any associa-
tions due to lack of statistical power.
The main strengths of this study are the large 
sample size and the population-based study design, 
which enabled us to assess the determinants in a truly 
unselected population. Knowledge on determinants in 
the general population is essential, as this forms the 
target population for interventions to prevent the devel-
opment and rupture of UIAs. However, some limitations 
have to be considered. First, we used a proton-density 
T2-weighted sequence to evaluate presence of UIAs, 
possibly leading to underestimation of the prevalence 
of aneurysms and decreasing our power. The slice 
thickness of the PDw sequence was 1.6 mm, mean-
ing that some aneurysms smaller than this might have 
been missed due to the limits in spatial resolution. 
However, although the found effects would be attenu-
ated, they would remain valid. On the other hand, it is 
also possible that people who were judged to have an 
UIA did not actually harbor one. Finally, another poten-
tial limitation is the relatively homogeneous constitu-
tion of this geographically defined study population, 
consisting primarily of white, middle-class persons.28 
Consequentially, our results may not be generalizable 
to other ethnic or socioeconomic groups.
Our results may have implications for clinical practice 
and future research. Although diet and physical activity 
show no association with the presence of UIAs, it is too 
early to rule out possible protective effects with respect 
to rupture risk, which was not studied here. Longitudi-
nal data, with detailed registration of diet and physical 
activity, or intervention studies focused on promoting a 
healthy diet and increased physical activity are necessary 
in the future to further elucidate their potential role. For 
now, preventive strategies should be primarily focused 
on treating hypertension and promoting cessation of 
smoking.
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